Incidences of type 2 diabetes (T2D) have reached epidemic proportions, with ~8.3% of the US population diagnosed and 79 million more exhibiting pre-diabetes - a reminder of the urgent need for solutions. Halting pre-diabetes development and progression to T2D requires a multi-pronged approach, since the pathophysiology involves both peripheral insulin resistance and pancreatic ? cell dysfunction. Each of these processes is rate-limited by the abundance of exocytosis t-SNARE (Soluble NSF Attachment Protein Receptor) proteins. Relatedly, a recent human islet study suggests that increasing expression of exocytosis proteins, such as the t-SNARE protein Syntaxin 4 (Syn4), may lead to improved regenerative approaches to treat diabetes. Loss of Syn4 abundance and/or its activity is associated with diabetes in human and rodent islets and skeletal muscle, tissues which regulate insulin release and insulin sensitivity, respectively. Thus, the long-term goal is to understand how Syn4 can be manipulated for treatment and prevention of prediabetes and T2D. Discovery of ways to target Syn4 abundance/activation to control glycemic dysregulation and prediabetes offers a tantalizing opportunity for disease intervention. The objective of this application is to determine how Syn4 enrichment/activation functions to enhance ?-cell insulin secretion and skeletal muscle insulin action both in vivo and at the molecular level, and how Syn4 abundance in these tissues is regulated. Preliminary data show that Syn4 protein is limiting for human islet insulin secretion;islets enriched with Syn4 more effectively reduce hyperglycemia in diabetic mice. Moreover, T2D human islets are ~40% deficient in Syn4 protein, as are islet and muscle cells of diabetic mice. Notably, restoration of Syn4 to human T2D islets can fully rescue insulin secretion. Syn4-enriched mice also resist age-and high-fat-diet induced insulin resistance. The central hypothesis is that diabetogenic stimuli underlie Syn4 deficiency to impair key regulated exocytosis events in ? cells and skeletal muscle cells, and that Syn4 upregulation can boost these processes to rescue/resist stress associated with prediabetes and T2D. The rationale for the proposed research is that once it is known how Syn4 enrichment promotes and/or protects functional ? cell mass and peripheral insulin sensitivity, and how Syn4 abundance is regulated, that Syn4 can be manipulated to avert disease in the face of diabetogenic stimuli.
Three Specific Aims are developed to test this: 1) Evaluate Syn4 upregulation in prevention/reversal of diabetogenic-induced ?-cell dysfunction, 2) Delineate how Syn4 enrichment/activation in skeletal muscle promotes insulin sensitivity, and 3) Determine the mechanistic basis for attenuated Syn4 expression in pre/diabetic tissues.
Aims will be accomplished using innovative inducible ?-cell- and skeletal muscle-specific Syn4 transgenic mice challenged with diabetogenic stimuli, peptide activators of endogenous Syn4, and live-cell imaging biosensors paired with biochemical assays using human tissues. Results will positively impact efforts to ameliorate disease as the identified mechanisms are highly likely to provide new therapeutic targets.

Public Health Relevance

Pre-diabetes and Type 2 diabetes has been coined a 'two-hit'disease;one 'hit'is dysfunction of glucose clearance by the skeletal muscle and adipose tissues, and another 'hit'is dysfunction of insulin secretion by the pancreatic islet beta cells. Aberrant abundance and function of a particular SNARE protein named Syntaxin 4 is associated with both 'hits'in human diabetes. The work proposed will identify the cause(s) of attenuated Syn4 associated with pre-diabetes and impact of Syn4 enrichment/activation upon mechanisms required for insulin secretion and glucose clearance, positively impacting efforts to ameliorate pre- and type 2-diabetes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Silva, Corinne M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University-Purdue University at Indianapolis
Schools of Medicine
United States
Zip Code
Blue, Emily K; Ballman, Kimberly; Boyle, Frances et al. (2015) Fetal hyperglycemia and a high-fat diet contribute to aberrant glucose tolerance and hematopoiesis in adult rats. Pediatr Res 77:316-25
Ramalingam, Latha; Yoder, Stephanie M; Oh, Eunjin et al. (2014) Munc18c: a controversial regulator of peripheral insulin action. Trends Endocrinol Metab 25:601-8
Yoder, Stephanie M; Dineen, Stacey L; Wang, Zhanxiang et al. (2014) YES, a Src family kinase, is a proximal glucose-specific activator of cell division cycle control protein 42 (Cdc42) in pancreatic islet ? cells. J Biol Chem 289:11476-87
Ramalingam, Latha; Oh, Eunjin; Thurmond, Debbie C (2014) Doc2b enrichment enhances glucose homeostasis in mice via potentiation of insulin secretion and peripheral insulin sensitivity. Diabetologia 57:1476-84
Ramalingam, Latha; Lu, Jingping; Hudmon, Andy et al. (2014) Doc2b serves as a scaffolding platform for concurrent binding of multiple Munc18 isoforms in pancreatic islet ?-cells. Biochem J 464:251-8
Kalwat, Michael A; Thurmond, Debbie C (2013) Signaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet * cells. Exp Mol Med 45:e37
Kalwat, Michael A; Yoder, Stephanie M; Wang, Zhanxiang et al. (2013) A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic ? cells. Biochem Pharmacol 85:808-16
Kalwat, Michael A; Wiseman, Dean A; Luo, Wei et al. (2012) Gelsolin associates with the N terminus of syntaxin 4 to regulate insulin granule exocytosis. Mol Endocrinol 26:128-41
Wiseman, Dean A; Kalwat, Michael A; Thurmond, Debbie C (2011) Stimulus-induced S-nitrosylation of Syntaxin 4 impacts insulin granule exocytosis. J Biol Chem 286:16344-54
Kepner, Erica M; Yoder, Stephanie M; Oh, Eunjin et al. (2011) Cool-1/?PIX functions as a guanine nucleotide exchange factor in the cycling of Cdc42 to regulate insulin secretion. Am J Physiol Endocrinol Metab 301:E1072-80

Showing the most recent 10 out of 27 publications